Effects of inhaled glaucine on pulmonary responses to antigen in sensitized guinea pigs

European Journal of Pharmacology

Volumn 397, Issue 1, 2000, Pages 187-195

  Pons, Ramón ^a   Santamarı́a, Pedro ^a   Suchankova, Jana ^a   Cortijo, Julio ^a   Morcillo, Esteban J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Airway eosinophil infiltration; Airway hyperreactivity; Airway microvascular leakage; Glaucine; Phosphodiesterase 4 inhibitor; Sensitized, guinea pig

Indexed keywords

ANTIGEN; GLAUCINE; PHOSPHODIESTERASE IV INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; ANTIGENS; APORPHINES; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; CAPILLARY PERMEABILITY; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHIL PEROXIDASE; EOSINOPHILS; GUINEA PIGS; HISTAMINE; LUNG; MALE; PEROXIDASES; PULMONARY CIRCULATION; TRACHEA; VASCULAR RESISTANCE;

EID: 0034717107     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00224-7     Document Type: Article

References (50)

1. Advenier C., Boissier J.R., Giudicelli J.F. Comparative study of six β-adrenoceptor antagonists on airway resistance and heart rate in the guinea pig. Br. J. Pharmacol. 44:1972;642-650.
2. Advenier C., Qian Y., Koune J.-D.L., Molimard M., Candenas M.-L., Naline E. Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea pig. Br. J. Pharmacol. 105:1992;792-798.
3. Amdur M.O., Mead J. Mechanics of respiration in unanaesthetized guinea pigs. Am. J. Physiol. 192:1958;364-368.
4. Andersson P. Antigen-induced bronchial anaphylaxis in actively sensitized guinea pigs. Allergy. 35:1980;65-71.
5. Banner K.H., Page C.P. Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea pigs. Br. J. Pharmacol. 114:1995;93-98.
6. Banner K.H., Moriggi E., Da Ros B., Schioppacassi G., Semeraro C., Page C.P. The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-astma drugs on inflammatory cell activation. Br. J. Pharmacol. 119:1996;1255-1261.
7. Banner K.H., Paul W., Page C.P. Ovalbumin challenge following immunization elicits recruitment of eosinophils but not bronchial hyperresponsiveness in guinea pigs: time course and relationship to eosinophil activation status. Pulm. Pharmacol. 9:1996;179-187.
8. Barnes P.J. Clinical studies with calcium antagonists in asthma. Br. J. Clin. Pharmacol. 20:1985;289S-298S.
9. Barnes P.J., Dollery C.T., MacDermot J. Increased pulmonary α-adrenergic and reduced β-adrenergic receptors in experimental asthma. Nature (London). 285:1980;569-571.
10. Barnes P.J., Ind P., Dollery C.T. Inhaled prazosin in asthma. Thorax. 36:1981;378-381.
11. Barnette M.S. Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD). Prog. Drug Res. 53:1999;195-229.
12. Black J.L., Armour C.L. α-Adrenoceptor function in asthma. Trends Pharmacol. Sci. 7:1986;303-304.
13. Boschetto P., Roberts N.M., Rogers D.F., Barnes P.J. Effect of antiasthma drugs on microvascular leakage in guinea pig airways. Am. Rev. Respir. Dis. 139:1989;416-421.
14. Coleman R.A. Current animal models are not predictive for clinical asthma. Pulm. Pharmacol. Ther. 12:1999;87-89.
15. Constant O., Slavin B., Lehane J.R., Jordan C., Jones J.G. Effect of the antitussive glaucine on bronchomotor tone in man. Thorax. 38:1983;537-542.
16. Cortijo J., Bou J., Beleta J., Cardelús I., Llenas J., Morcillo E., Gristwood R.W. Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. Br. J. Pharmacol. 108:1993;562-568.
17. Cortijo J., Villagrasa V., Pons R., Berto L., Martí-Cabrera M., Martinez-Losa M., Domenech T., Beleta J., Morcillo E.J. Bronchodilator and anti-inflammatory activities of glaucine: in vitro studies in human airway smooth muscle and polymorphonuclear leukocytes. Br. J. Pharmacol. 127:1999;1641-1651.
18. Daffonchio L., Lees I.W., Payne A.N., Whittle B.J.R. Pharmacological modulation of bronchial anaphylaxis induced by aerosol challenge in anaesthetized guinea pigs. Br. J. Pharmacol. 91:1987;701-708.
19. Dierckx P., Leblanc G., Decoster A., Criscuolo D. Double blind study of glaucine in chronic cough. Int. J. Clin. Pharmacol. 19:1981;396-399.
20. Fanta C.H., Venugopalan C.S., Lacouture P.G., Drazen J.M. Inhibition of bronchoconstriction in the guinea pig by a calcium channel blocker, nifedipine. Am. Rev. Respir. Dis. 125:1982;61-66.
21. Farmer S.G., Wilkins D.E., Meeker S.A., Seeds E.A.M., Page C.P. Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia in guinea pigs. Br. J. Pharmacol. 107:1992;653-659.
22. Gastpar H., Criscuolo D., Dieterich H.A. Efficacy and tolerability of glaucine as an antitussive agent. Curr. Med. Res. Opin. 9:1984;21-27.
23. Guyton A.C. Measurement of the respiratory volumes of laboratory animals. Am. J. Physiol. 150:1947;70-77.
24. m cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. J. Pharmacol. Exp. Ther. 251:1989;199-206.
25. Havill A.M., Van Valen R.G., Handley D.A. Prevention of non-specific airway hyperreactivity after allergen challenge in guinea pigs by the PAF receptor antagonist SDZ 64-412. Br. J. Pharmacol. 99:1990;396-400.
26. Hertz F., Cloarec A. Comparative effects of various calcium entry blockers and anti-asthmatic compounds on antigen-induced bronchoconstriction in rat and histamine release from rat mast cells. Int. J. Immunopharmacol. 8:1986;747-754.
27. Hui K.P., Lötvall J., Chung K.F., Barnes P.J. Attenuation of inhaled allergen-induced airway microvascular leakage and airflow obstruction in guinea pigs by a 5-lipoxygenase inhibitor (A-63162). Am. Rev. Respir. Dis. 143:1991;1015-1019.
28. 1-adrenoceptor and benzothiazepine binding site at the calcium channel. Br. J. Pharmacol. 106:1992;387-394.
29. Karlsson J.A., Lanner A.S., Persson C.G.A. Airway opioid receptors mediate inhibition of cough and reflex bronchoconstriction in guinea pigs. J. Pharmacol. Exp. Ther. 252:1990;863-868.
30. Kasé Y., Kawaguchi M., Takahama K., Miyata T., Hirotsu I., Hitoshi T., Okano Y. Pharmacological studies on DL-glaucine phosphate as an antitussive. Arzneim.-Forsch. 33:1983;936-946.
31. Korach E.S., Carnathan G.W., Aspinall R.L. The effect of calcium antagonists on allergic pulmonary distress in actively sensitized rats. Allergy. 42:1987;576-582.
32. Kukovetz W.R., Poch G. Inhibition of cyclic-3′,5′-nucleotide phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs. Naunyn-Schmiedeberg's Arch. Pharmacol. 267:1970;189-194.
33. Lagente V., Moodley I., Perrin S., Mottin G., Junien J.L. Effects of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea pig lung. Eur. J. Pharmacol. 255:1994;253-256.
34. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
35. Malo P.E., Wasserman M.A., Griffin R.L. The effects of nifedipine and verapamil on antigen-induced bronchoconstriction in dogs. Eur. J. Pharmacol. 92:1983;69-75.
36. Orallo F., Alzueta A.F., Loza M.I., Vivas N., Badia A., Campos M., Honrubia M.A., Cadavid M.I. Study of the mechanism of the relaxant action of (+)-glaucine in rat vas deferens. Br. J. Pharmacol. 110:1993;943-948.
37. Ortiz J.L., Cortijo J., Vallés J.M., Bou J., Morcillo E.J. Rolipram inhibits airway microvascular leakage induced by platelet-activating factor, histamine and bradykinin in guinea pigs. J. Pharm. Pharmacol. 45:1993;1090-1092.
38. Ortiz J.L., Valles J.M., Marti-Cabrera M., Cortijo J., Morcillo E.J. Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;200-206.
39. Pretolani M., Ruffié C., Joseph D., Campos M.G., Church M.K., Lefort J., Vargaftig B.B. Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. Am. J. Respir. Crit. Care Med. 149:1994;1167-1174.
40. Raeburn D., Karlsson J.A. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase inhibitors on microvascular leak in guinea pig airways in vivo. J. Pharmacol. Exp. Ther. 267:1993;1147-1152.
41. Raeburn D., Underwood S.L., Lewis S.A., Woodman V.R., Battram C.H., Tomkinson A., Sharma S., Jordan R., Souness J.E., Webber S.E., Karlsson J.-A. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br. J. Pharmacol. 113:1994;1423-1431.
42. 2-adrenoceptor agonist platelet-activating factor-induced airway microvascular leakage and bronchoconstriction in the guinea pig. Agents Actions. 40:1993;50-56.
43. Schlesinger R.B. Comparative deposition of inhaled aerosols in experimental animals and humans. A review. J. Toxicol. Environ. Health. 15:1985;197-214.
44. Small R.C., Berry J.L., Boyle J.P., Chapman I.D., Elliott K.R.F., Foster R.W., Watt A.J. Biochemical and electrical aspects of the tracheal relaxant action of AH 21-132. Eur. J. Pharmacol. 192:1991;417-426.
45. Strath M., Warren D.J., Sanderson C.J. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J. Immunol. Methods. 83:1985;209-215.
46. Teixeira M.M., Gristwood R.W., Cooper N., Hellewell P.G. Phosphodiesterase (PDE) 4 inhibitors: anti-inflammatory drugs of the future? Trends Pharmacol. Sci. 18:1997;164-171.
47. Thompson W.J., Strada S.J. Cyclic nucleotide phosphodiesterase (PDE). Bergmayer H.U. 3rd edn. Methods of Enzymatic Analysis. vol. IV:1984;127-134 Verlag Chemie, Weinheim.
48. Torphy T.J. Phosphodiesterase isozymes. Molecular targets for novel antiasthma agents (State of the art). Am. J. Respir. Crit. Care Med. 157:1998;351-370.
49. Underwood D.C., Osborn R.R., Novak L.B., Matthews J.K., Newsholme S.J., Undem B.J., Hand J.M., Torphy T.J. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J. Pharmacol. Exp. Ther. 266:1993;306-313.
50. Van Inwegen R.G., Salaman P., St. Georgier V., Weinryb I. Dihydro and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Biochem. Pharmacol. 28:1979;1307-1312.